Role of HIPEC after Complete Cytoreductive Surgery (CRS) in Peritoneal Recurrence of Platinum-Sensitive Recurrent Ovarian Cancer (OC): The Aim for Standardization at Two Reference Centers for CRS.

Miklos Acs,Michael Gerken,Vanessa Schmitt,Pompiliu Piso,Alfred Königsrainer,Saher Baransi,Can Yurttas,Sebastian Häusler,Philipp Horvath

Cancers（2023）

引用 0|浏览8

暂无评分

摘要

In well-selected patients with platinum-sensitive recurrent ovarian cancer, survival may correlate with complete CRS and 90 min cisplatin-based HIPEC. We confirmed the results of primary OC studies; therefore, this combination should be used for further analysis in the recurrent situation.

查看译文

关键词

HIPEC,cytoreductive surgery,platinum-sensitive,recurrent ovarian cancer

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要